鉴于扭转蛋白A表达上调具有潜在的治疗原发性早发扭转性肌张力障碍的前景,影响其分布和表达的分子机制需要进一步研究。
We should pay more attention on the mechanisms of the expression of TorsinA protein for the potential therapies to early-onset primary torsion dystonia ( DYT1 ) .